Jaguar Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. on April 9, 2021, with the report date of April 15, 2021. The filing addresses a corporate action regarding the company's capital raising activities under an existing At-The-Market (ATM) offering agreement.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The primary financial metric disclosed is the authorization to increase the size of the ATM offering by an aggregate offering price of $15.3 million.
Material Changes
- ATM Offering Upsize: The Company filed a Rule 462(b) registration statement to increase the size of its previously disclosed ATM offering with Ladenburg Thalmann & Co. Inc. by $15.3 million.
- Regulatory Status: The 462(b) Registration Statement became effective immediately upon filing on April 9, 2021.
Guidance, Outlook, and Management Commentary
Management announced the ATM Upsize via a press release dated April 15, 2021, which is included as Exhibit 99.1. The filing notes that the press release contains "certain additional commercial updates," but the text of this 8-K does not detail those updates or provide specific forward-looking guidance, risk factors, or contingencies beyond the standard securities law disclaimers regarding the sale of shares.
Investor Verification Checklist
- Verify the total remaining capacity of the ATM offering after the $15.3 million upsize.
- Review the press release (Exhibit 99.1) for the specific "commercial updates" mentioned but not detailed in this filing.
- Confirm the current share price and dilution impact of potential future sales under the expanded ATM agreement.
- Check subsequent filings for actual proceeds raised under the upsize.